|
641 |
Utility Estimation in Chronic Obstructive Pulmonary Disease
Enthalten in PharmacoEconomics Bd. 29, 11.10.2012, Nr. 11, date:11.2011: 917-932
|
|
|
|
642 |
Vaccine-Based Subgroup Analysis in VigiBase
Enthalten in Drug safety Bd. 35, 9.1.2013, Nr. 4, date:4.2012: 335-346
|
|
|
|
643 |
Validity of Cost and Utility Results?
Enthalten in PharmacoEconomics Bd. 30, 27.12.2012, Nr. 10, date:10.2012: 977
|
|
|
|
644 |
Value-of-Information Analysis to Reduce Decision Uncertainty Associated with the Choice of Thromboprophylaxis after Total Hip Replacement in the Irish Healthcare Setting
Enthalten in PharmacoEconomics Bd. 30, 27.12.2012, Nr. 10, date:10.2012: 941-959
|
|
|
|
645 |
Vancomycin
Enthalten in Clinical pharmacokinetics Bd. 51, 13.9.2012, Nr. 1, date:1.2012: 1-13
|
|
|
|
646 |
Vinflunine Oral Pharmacokinetics and Absolute Bioavailability of Soft and Hard Gelatin Capsules
Enthalten in Clinical pharmacokinetics Bd. 51, 13.12.2012, Nr. 6, date:6.2012: 357-364
|
|
|
|
647 |
Vitiligo in an Italian Outpatient Center
Enthalten in American journal of clinical dermatology Bd. 12, 10.9.2012, Nr. 1, date:2.2011: 43-49
|
|
|
|
648 |
What’s Good and Bad About Contraceptive Products?
Enthalten in PharmacoEconomics Bd. 30, 23.12.2012, Nr. 12, date:12.2012: 1187-1202
|
|
|
|
649 |
WHO Essential Medicines List for Children
Enthalten in Pediatric drugs Bd. 13, 31.8.2012, Nr. 4, date:8.2011: 209-211
|
|
|
|
650 |
Why Do Pedometers Work?
Enthalten in Sports medicine Bd. 39, 1.12.2009, Nr. 12, date:12.2009: 981-993
|
|
Administration
